ACXP Acurx Pharmaceuticals, Inc. - Common Stock
$1,87
Kurs · Mai 20, 2026
Fundamentaldaten per Mai 11, 2026
52W-Spanne
$1–$21
3% of range
Analystenbewertung
BUY
9 analysts
Kursziel
$17
+809% upside
P/E (TTM)
-0.5
ROE
-180.3%
Nettogewinnmarge
—
ACXP Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.87
Marktkapitalisierung
$6M
P/E (TTM)
-0.5
EPS (TTM)
$-5.32
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-180.3%
Verschuldungsgrad
—
52W-Spanne
$1 – $21
ACXP Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-5.32
2020-12-31
→
2025-12-31
Freier Cashflow
—
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ACXP
Peer-Median
P/E (TTM)
-0.5
—
P/B (K/B)
1.1
1.0
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ACXP
Peer-Median
ROA
-138.0%
-89.8%
ROE
-180.3%
-215.6%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ACXP
Peer-Median
Quick Ratio
3.1
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ACXP
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ACXP
Peer-Median
ACXP Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
9 Analysten
- Starker Kauf 2 22,2%
- Kauf 6 66,7%
- Halten 1 11,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
3 Analysten · 2026-05-15
Median
$10.00
Mittelwert
$17.00
← Unter allen Zielen
$1.87
Tief
$10.00
Hoch
$31.00
Median-Ziel
$10.00
+434,8%
Mittelwert-Ziel
$17.00
+809,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.42%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.62 | $-0.65 | 0.03% |
| 31. Dezember 2025 | $-0.31 | $-1.01 | 0.70% |
| 30. September 2025 | $-1.23 | $-1.34 | 0.11% |
| 30. Juni 2025 | $-1.89 | $-2.31 | 0.42% |
| 31. März 2025 | $-2.20 | $-3.06 | 0.86% |
Vergleich mit Konkurrenten Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ACXP | $6M | -0.5 | — | — | -180.3% | — |
| GNPX | $6M | — | — | — | -347.0% | — |
| PMCB | $8M | 0.4 | — | — | 66.5% | — |
| GOVX | $296.2K | — | -37.1% | -862.3% | -645.9% | — |
| BIAF | — | — | — | — | — | — |
| HCWB | — | -0.1 | -97.9% | -14677.1% | -586.8% | 20.0% |
| XBIO | — | -1.4 | 19.0% | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $5M | $6M | $5M | $2M | $2M | |
| SG&A Expense | $6M | $9M | $9M | $7M | $11M | · | |
| Operating Expenses | $8M | $14M | $15M | $12M | $13M | $5M | |
| Operating Income | $-8M | $-14M | · | · | · | · | |
| Interest Income | $125.4K | $20.1K | · | · | · | · | |
| Income Tax | · | · | · | $0 | · | $0 | |
| Net Income | $-8M | $-14M | $-15M | $-12M | $-13M | $-5M | |
| EPS (Basic) | $-5.32 | $-17.45 | $-1.15 | $-1.12 | $-1.49 | $-0.74 | |
| EPS (Diluted) | $-5.32 | $-17.45 | $-1.15 | $-1.12 | $-1.49 | $-0.74 | |
| Shares (Basic) | 1,498,793 | 808,168 | 12,671,572 | 10,816,412 | 8,535,873 | 6,190,875 | |
| Shares (Diluted) | 1,498,793 | 808,168 | 12,671,572 | 10,816,412 | 8,535,873 | 6,190,875 | |
| EBITDA | $-8M | · | · | · | · | · |
Bilanz 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $4M | $7M | $9M | $13M | $3M | |
| Prepaid Expense | $85.0K | $100.1K | $105.8K | $265.0K | $295.3K | $48.6K | |
| Current Assets | · | $4M | $8M | $9M | $13M | · | |
| Total Assets | $8M | $4M | $8M | $9M | $13M | $3M | |
| Accounts Payable | $2M | $3M | $3M | $2M | $843.9K | $455.9K | |
| Current Liabilities | $2M | $3M | $3M | $2M | $843.9K | $472.6K | |
| Total Liabilities | $2M | $3M | $3M | $2M | $843.9K | $522.4K | |
| Common Stock | $2.3K | $852 | $14.5K | $11.6K | $10.2K | · | |
| Paid-in Capital | $81M | $68M | $58M | $46M | $39M | · | |
| Retained Earnings | $-75M | $-67M | $-53M | $-39M | $-27M | $-14M | |
| Stockholders' Equity | $5M | $615.1K | $5M | $7M | $12M | $3M | |
| Liabilities + Equity | $8M | $4M | $8M | $9M | $13M | $3M | |
| Shares Outstanding | 2,348,113 | 851,534 | 723,411 | 11,627,609 | 10,215,792 | 0 |
Cashflow 6
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $3M | $3M | $3M | $5M | $695.8K | |
| Operating Cash Flow | $-7M | $-10M | $-10M | $-8M | $-5M | $-3M | |
| Stock Issued | · | · | · | $4M | · | · | |
| Net Stock Activity | · | · | · | $4M | · | · | |
| Financing Cash Flow | $11M | $7M | $8M | $4M | $15M | $4M | |
| Net Change in Cash | $4M | $-4M | $-2M | $-4M | $10M | $692.1K |
Rentabilität 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -138.0% | -243.8% | -170.6% | -106.9% | -154.7% | · | |
| ROE | -180.3% | -860.2% | -339.0% | -141.6% | · | · |
Liquidität & Solvenz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Quick Ratio | 3.1 | 1.1 | 2.5 | 4.4 | 15.4 | · |
Bewertung (TTM) 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-8M | $-14M | $-15M | $-12M | $-13M | · | |
| Market Cap | $6M | $277M | $1.11B | $926M | $883M | · | |
| P/E | -0.5 | -0.9 | -66.6 | -71.1 | -58.0 | · | |
| P/B | 1.1 | 450.7 | 237.5 | 126.5 | · | · | |
| P / Tangible Book | 1.1 | 450.7 | 237.5 | 126.5 | 71.1 | · | |
| P / Cash Flow | -0.9 | -26.7 | -113.1 | -122.7 | -176.1 | · | |
| Earnings Yield | -213.6% | -107.2% | -1.5% | -1.4% | -1.7% | · |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $341.5K | $281.8K | $429.7K | $524.2K | $598.8K | $825.1K | $1M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $2M | $911.7K | |
| SG&A Expense | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | $4M | $3M | |
| Operating Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | · | · | · | · | · | · | · | · | |
| Interest Income | $35.0K | $38.8K | $35.9K | $23.4K | $27.3K | $12.0K | $5.0K | $782 | · | · | · | · | · | · | · | · | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Net Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-4M | $-5M | $-3M | $-3M | $-3M | $-3M | $-4M | $-3M | |
| EPS (Basic) | $-0.62 | $-2.09 | $-1.23 | $-1.89 | $-2.15 | $-8.51 | $-3.45 | $-5.21 | $-0.28 | $-0.38 | $-0.24 | $-0.28 | $-0.25 | $-0.28 | $-0.32 | $-0.26 | |
| EPS (Diluted) | $-0.62 | $-2.09 | $-1.23 | $-1.89 | $-2.15 | $-8.51 | $-3.45 | $-5.21 | $-0.28 | $-0.38 | $-0.24 | $-0.28 | $-0.25 | $-0.28 | $-0.32 | $-0.26 | |
| Shares (Basic) | 2,718,433 | -21,355,926 | 1,625,805 | 1,190,266 | 1,001,932 | -16,273,746 | 818,174 | 791,233 | 15,472,507 | -24,159,432 | 13,005,128 | 12,186,481 | 11,639,395 | -20,828,035 | 11,148,402 | 10,263,202 | |
| Shares (Diluted) | 2,718,433 | -21,355,926 | 1,625,805 | 1,190,266 | 1,001,932 | -16,273,746 | 818,174 | 791,233 | 15,472,507 | -24,159,432 | 13,005,128 | 12,186,481 | 11,639,395 | -20,828,035 | 11,148,402 | 10,263,202 | |
| EBITDA | $-2M | · | $-2M | $-2M | · | · | · | · | · | · | · | · | · | · | · | · |
Bilanz 13
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $8M | $6M | $6M | $5M | $4M | $6M | $6M | $9M | $7M | $7M | $9M | $7M | $9M | $11M | $9M | |
| Prepaid Expense | $228.8K | $85.0K | $158.2K | $53.5K | $161.6K | $100.1K | $122.8K | $168.4K | $187.9K | $105.8K | $105.7K | $89.9K | $206.6K | $265.0K | $337.8K | $116.9K | |
| Current Assets | · | · | · | $6M | $5M | · | $6M | · | · | · | $7M | $9M | $7M | · | $11M | $9M | |
| Total Assets | $10M | $8M | $6M | · | · | $4M | · | $7M | $9M | $8M | · | · | · | $9M | · | $9M | |
| Accounts Payable | $3M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $473.9K | |
| Current Liabilities | $3M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $473.9K | |
| Total Liabilities | $3M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $473.9K | |
| Common Stock | $3.4K | $2.3K | $1.8K | $1.5K | $22.4K | $852 | $16.8K | $16.0K | $15.8K | $14.5K | $13.0K | $13.0K | $11.7K | $11.6K | $11.6K | $10.3K | |
| Paid-in Capital | $84M | $81M | $77M | $75M | $72M | $68M | $67M | $65M | $64M | $58M | $52M | $51M | $47M | $46M | $45M | $41M | |
| Retained Earnings | $-77M | $-75M | $-74M | $-72M | $-69M | $-67M | $-65M | $-62M | $-58M | $-53M | $-48M | $-45M | $-42M | $-39M | $-35M | $-32M | |
| Stockholders' Equity | $7M | $5M | $4M | $4M | $2M | $615.1K | $3M | $3M | $6M | $5M | $4M | $6M | $5M | $7M | $10M | · | |
| Liabilities + Equity | $10M | $8M | $6M | $6M | $5M | $4M | $6M | $7M | $9M | $8M | $7M | $9M | $7M | $9M | $11M | $9M | |
| Shares Outstanding | 3,389,106 | 2,348,113 | 1,800,299 | 1,470,352 | 22,397,511 | 851,534 | 16,770,378 | 15,996,168 | 15,757,102 | 14,468,229 | 13,005,128 | 13,005,128 | 11,671,795 | 11,627,609 | 11,592,609 | 10,263,202 |
Cashflow 4
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $258.3K | $294.8K | $294.8K | $324.2K | $333.6K | $345.2K | $345.2K | $1M | $894.5K | $833.3K | $833.3K | $806.5K | $733.5K | $697.0K | $697.0K | $716.7K | |
| Operating Cash Flow | $-1M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-2M | $-2M | $-2M | $-1M | $-2M | $-2M | |
| Financing Cash Flow | $3M | $3M | $2M | $3M | $3M | $194.5K | $2M | $320.2K | $5M | $5M | $0 | · | · | $-1 | · | · | |
| Net Change in Cash | $2M | $2M | $-157.3K | $1M | $937.2K | $-2M | $-598.3K | $-3M | $1M | $421.9K | $-2M | $2M | $-2M | $-1M | $2M | $-2M |
Rentabilität 2
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.0% | · | -18.9% | · | · | · | · | -52.0% | -42.9% | · | · | · | · | · | · | -19.6% | |
| ROE | -36.1% | · | -63.2% | -64.2% | -51.7% | · | -85.5% | -85.5% | -77.4% | · | -45.5% | -110.8% | -109.3% | · | -72.5% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | 2.4 | 1.9 | · | 1.8 | · | · | · | 2.2 | 3.1 | 3.6 | · | 9.3 | 19.4 | |
| Quick Ratio | 3.7 | · | 2.4 | 2.3 | 1.9 | · | 1.7 | 2.0 | 2.9 | · | 2.2 | 3.0 | 3.5 | · | 9.0 | 19.2 |
Bewertung (TTM) 7
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-8M | · | $-9M | $-11M | $-13M | · | $-14M | $-15M | $-14M | · | $-13M | $-13M | $-12M | · | $-13M | $-14M | |
| Market Cap | $13M | · | $8M | $15M | $175M | · | $637M | $720M | $772M | · | $390M | $689M | $808M | · | $696M | $778M | |
| P/E | -0.6 | · | -0.6 | -1.0 | -0.9 | · | -4.1 | -7.5 | -46.7 | · | -27.5 | -47.7 | -63.5 | · | -46.2 | -48.9 | |
| P/B | 1.8 | · | 2.1 | 4.2 | 75.6 | · | 239.2 | 210.0 | 128.7 | · | 99.2 | 110.9 | 152.1 | · | 71.2 | · | |
| P / Tangible Book | 1.8 | · | 2.1 | 4.2 | 75.6 | · | 239.2 | 210.0 | 128.7 | · | 99.2 | 110.9 | 152.1 | · | 71.2 | · | |
| P / Cash Flow | -8.9 | · | · | · | -85.2 | · | · | · | -252.1 | · | · | · | -417.9 | · | · | · | |
| Earnings Yield | -158.8% | · | -155.7% | -104.3% | -116.0% | · | -24.2% | -13.4% | -2.1% | · | -3.6% | -2.1% | -1.6% | · | -2.2% | -2.0% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-8M | $-14M | $-15M | $-12M | $-13M |
| Verwässerte EPS | $-5.32 | $-17.45 | $-1.15 | $-1.12 | $-1.49 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Quick Ratio | 3.1 | 1.1 | 2.5 | 4.4 | 15.4 |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.